Isokinetic Strength and Balance Assessment in Diabetic Patients

NCT05770154 | Completed

• 1 other identifier: isokinetic in diabetic
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Diabetic polyneuropathy (DPN) is a type of nerve damage that can occur in diabetics. It can cause weakness and a loss of sensation, particularly in the legs and feet. This can have an impact on muscle strength and balance, making walking more difficult and increasing the risk of falling. Evaluating ankle muscular strength and balance using quantitative and standardised tools is critical for patients with and without DPN as well as determining how much DPN affects ankle muscle strength and balance.

Conditions

Diabetes

Keywords

diabetes,; diabetic polyneuropathy; isokinetic; muscle strength; dynamic balance

Outcome Measures

Primary Outcomes (1)

• Peak torque

  Isokinetic dynamometer will be used for measuring ankle dorsi and planter flexors peak torque at different angular velocities.

  Through study completion, an average of 6 months.

Secondary Outcomes (3)

• Power

  Through study completion, an average of 6 months.

• Work

  Through study completion, an average of 6 months.

• Dynamic balance

  Through study completion, an average of 6 months.

Eligibility Criteria

• Age: 40 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

diabetic patient

You may qualify if:

• Patients aged from 40 to 55 years for both gender.
• Patients with diabetes for more than 5 years.
• Diabetic polyneuropathy was diagnosed by a neurologist.
• Their BMI from 18 to 24.9 kg/m2.
• The study population must be willing to participate in the study.

You may not qualify if:

• Patients with marked deformities of the lower limbs, foot ulcers and Charcot foot.
• Patients with any other neurological or orthopedic diseases that may affect balance.
• Patients with marked weakness or drop foot.
• Patients with amputation, mental deficits, liver or renal diseases.
• patients who had a previous surgical history (within 6 months) were also excluded prior to the baseline assessment

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Doaa Ayoub Elimy

Cairo, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus; Diabetic Neuropathies

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Diabetes Complications

Study Officials

• Doaa A Elimy, phD

  Cairo University

  PRINCIPAL INVESTIGATOR

• Khaled T Ahmed, Ass. prof

  Misr University for Science and Technology

  PRINCIPAL INVESTIGATOR

• Wafaa A Abd Allah, phD

  Misr University for Science and Technology

  PRINCIPAL INVESTIGATOR

• Mohamed F Abdel-lateef, phD

  Misr University for Science and Technology

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of physical therapy for basic science department., faculty of physical Therapy

Study Record Dates

• First Submitted: February 15, 2023
• First Posted: March 15, 2023
• Study Start: March 15, 2023
• Primary Completion: December 30, 2024
• Study Completion: December 30, 2024
• Last Updated: February 18, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: 6 months after publication
• Access Criteria: Study protocol

Locations

EG (1)